skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Tiotropium bromide inhibits TGF-ß-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro

Original Research

(2051) Views  (643) Full article downloads

Authors: Kazuhito Asano, Yusuke Shikama, Naruo Shoji, et al.

Published Date August 2010 Volume 2010:5 Pages 277 - 286
DOI: http://dx.doi.org/10.2147/COPD.S11737

Kazuhito Asano1, Yusuke Shikama2, Naruo Shoji3, Kojiro Hirano3, Harumi Suzaki3, Hiroaki Nakajima2

1Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama, Japan; 2Department of Respiratory Diseases, Showa University Northern Yokohamashi Hospital, Yokohama, Japan; 3Department of Otorhinolaryngology, School of Medicine, Showa University, Tokyo, Japan

Background: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation and structural alterations (ie, tissue remodeling) throughout the conducting airways, parenchyma, and pulmonary vasculature. Matrix metalloproteinases (MMPs) are extracellular degrading enzymes that play a critical role in inflammatory cell infiltration and tissue ­remodeling, but the influence of the agents that are used for the treatment of COPD on the production of MMPs is not well understood.

Purpose: The present study aimed to examine the influence of tiotropium bromide hydrate (TBH) on the production of MMPs from lung fibroblasts (LFs) induced by transforming growth factor (TGF)-ß in vitro.

Methods: LFs, at a concentration of 5 × 105 cells·mL-1, were stimulated with TGF-ß in the presence of various concentrations of TBH. MMP-1 and MMP-2 levels in culture ­supernatants were examined by enzyme-linked immunosorbent assay (ELISA), and MMP messenger ribonucleic acid (mRNA) expression was examined by real-time polymerase chain reaction (RT-PCR). The influence of TBH on TGF-ß signaling pathways was also analyzed by ­examining Smad activation and signaling protein phosphorylation by ELISA.

Results: TBH at more than 15 pg·mL-1 inhibited the production of MMP-1 and MMP-2, but not tissue inhibitor of matrix metalloproteinase (TIMP)-1 and TIMP-2, from LFs, after TGF-ß stimulation. TBH also suppressed MMP mRNA expression through the inhibition of Smad activation and signaling protein, extracellular-signal-regulated kinase (ERK) 1 and 2, and c-Jun N-terminal kinase (JNK), phosphorylation.

Conclusion: These results may suggest that TBH suppresses MMP production from LFs, through interference of TGF-ß-mediated signaling pathways and results in favorable modification of the clinical status of COPD.

Keywords: tiotropium bromide, matrix metalloproteinases, lung fibroblast, TGF-ß, inhibition, in vitro




 

Other articles by Dr Kazuhito Asano



Readers of this article also read:

Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on healthrelated quality of life
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
A validated disease specific prediction equation for resting metabolic rate in underweight patients with COPD
Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD
Budesonide/formoterol combination in COPD: a US perspective
Development and implementation of treadmill exercise testing protocols in COPD
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio